P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA‐C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG‐TERM RESULTS OF THE GELTAMO GROUP BRESHAP STUDY

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 973 - 974
Main Authors Garcia‐Sanz, R., Martínez, C., De la Cruz, F., González, A. P., Rodríguez, A., Sánchez‐González, B., Domingo‐Domenech, E., Moreno, M., López, J., Piñana, J. L., Bastos, M., Canales, M., Gutiérrez, A., Rodríguez‐Salazar, M. J., Navarro, A., Sureda, A.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000847200.09935.17